Fast moving consumer goods (FMCG) company Adani Wilmar, known for edible oil 'Fortune', has filed its DRHP with the market regulator to launch a ₹4,500 crore IPO.Adani Wilmar is a joint venture between Adani Group and Singapore-based Wilmar which was formed in 1999. It sells cooking oils under the Fortune brand as well as various other food products like rice and sugar. Retail wealth management firm Prudent Corporate Advisory Services is planning to launch an IPO of the entire offer for sale of 85.49 lakh shares. The IPO will see private equity firm TA Associates making a partial exit.The company provides wealth management services to 7.73 lakh unique retail investors through 17,583 mutual fund distributors (MFDs) across branches in 105 locations in 20 states in the country.It offers digital wealth management solutions through platforms like FundzBazar, PrudentConnect, Policyworld, WiseBasket and CreditBasket.Bain Capital-backed Emcure Pharmaceuticals is looking to raise ₹1,100 crore via fresh issue of shares and rest via offer of sale of 1.81 crore equity shares by promoters and existing shareholders.Investor Bain Capital owns 13.09% stake in the company and will divest 99.5 lakh equity shares among others. The Pune-based company is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company has a presence in 70 markets globally. Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.Raipur-based integrated steel manufacturer Shri Bajrang Power & Ispat is looking to raise ₹700 crore through public listing. Further, it willThe company will use ₹400 crore from the IPO proceeds to pay its debt of ₹840 crore. It is one of the leading integrated steel companies based out of central India and is among 10 players in India in terms of capacity for iron ore pellets, iron ore beneficiation and sponge iron. Further, it wants to expand its production capacity in sponge iron, steel melting, rolling mill, ferro alloys, and captive power. It also wants to set up a galvanising plant, which is expected to be completed within FY22. The medical devices company is looking to raise ₹1,500 crore via IPO, which comprises fresh issue of ₹410.33 crore and offer for sale of ₹1,089.67 crore.The medical devices company researches, designs, develops, manufactures and markets vascular devices globally across 69 countries. It operates three research and development facilities, located in Surat, India, Galway, Ireland and Nonthaburi, Thailand. The company intends to utilise the net proceeds from the issue towards paying off debt of ₹255 crore and rest for funding working capital requirement of its indirect foreign subsidiaries.